LEADER 00987nam2-2200349---450 001 990003296480203316 005 20220531102914.0 035 $a000329648 035 $aUSA01000329648 035 $a(ALEPH)000329648USA01 035 $a000329648 100 $a20090723d2007----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $aa|||z|||001yy 200 1 $a1: <> processi formativi$fEmilio Biagini 205 $a2. ed 210 $aGenova$cECIG$d2007 215 $a537 p.$cill.$d24 cm 225 2 $aGeografia e scienze ambientali$v4 410 0$12001$aGeografia e scienze ambientali 461 0$1001000172221$12001$aAmbiente, conflitto e sviluppo 607 $aIsole britanniche$xStoria$2BNCF 676 $a941 700 1$aBIAGINI,$bEmilio$075759 801 0$aIT$bsalbc$gISBD 912 $a990003296480203316 951 $aX.4. 92/1$b218100 L.M.$cX.4.$d00227891 959 $aBK 969 $aUMA 996 $aProcessi formativi$91122510 997 $aUNISA LEADER 03744nam 2200649Ia 450 001 9910781187903321 005 20230721005829.0 010 $a0-309-14874-X 010 $a1-282-45484-6 010 $a9786612454844 010 $a0-309-13045-X 035 $a(CKB)2550000000010224 035 $a(EBL)3378570 035 $a(SSID)ssj0000410972 035 $a(PQKBManifestationID)11293010 035 $a(PQKBTitleCode)TC0000410972 035 $a(PQKBWorkID)10351764 035 $a(PQKB)10755782 035 $a(MiAaPQ)EBC3378570 035 $a(Au-PeEL)EBL3378570 035 $a(CaPaEBR)ebr10364020 035 $a(CaONFJC)MIL245484 035 $a(OCoLC)923280829 035 $a(EXLCZ)992550000000010224 100 $a20090930d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAddressing the threat of drug-resistant tuberculosis$b[electronic resource] $ea realistic assessment of the challenge : workshop summary /$fRobert Giffin and Sally Robinson, rapporteurs; Institute of Medicine of the National Academies 210 $aWashington, D.C. $cNational Academies Press$d2009 215 $a1 online resource (253 p.) 300 $a"The Institute of Medicine's (IOM's) Forum on Drug Discovery, Development, and Translation held a workshop in Washington, DC, on November 5, 2008"--p. 2. 311 $a0-309-13044-1 320 $aIncludes bibliographical references. 327 $aReviewers -- Contents -- Tables, Figures, and Boxes -- Acronyms -- Summary -- Chapter 1. Introduction -- Chapter 2. The Global Spread of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis -- Chapter 3. MDR TB Transmission, HIV Coinfection, and Transmission Control -- Chapter 4. Diagnosis -- Chapter 6. Infrastructure and Health Care Delivery Systems -- 6 Global Systems for the Purchase and Delivery of TB Drugs -- Chapter 7. Research on the Global Control of TB: Understanding the Role of Drugs, Vaccines, and Funding -- Chapter 8. Strategies for Confronting the Global MDR and XDR TB Crisis -- References. -- Appendix A: Agenda -- Appendix B: Participant Biographies -- Appendix C: Partners In Health White Paper' stemming the Tide of Multidrug-Resistant Tuberculosis: Major Barriers to Addressing the Growing Epidemic -- 330 $a"Tuberculosis is one of the leading causes of death in the world today, with 4,500 people dying from the disease every day. Many cases of TB can be cured by available antibiotics, but some TB is resistant to multiple drugs--a major and growing threat worldwide. The Institute of Medicine's Forum on Drug Discovery, Development, and Translation hosted a workshop on November 5, 2008, to address the mounting concern of drug-resistant TB. The session brought together a wide range of international experts to discuss what is known and not known about this growing threat, and to explore possible solutions."--Publisher's website. 606 $aMultidrug-resistant tuberculosis$vCongresses 606 $aTuberculosis$vCongresses 606 $aDrug resistance$vCongresses 606 $aAntitubercular agents$vCongresses 615 0$aMultidrug-resistant tuberculosis 615 0$aTuberculosis 615 0$aDrug resistance 615 0$aAntitubercular agents 676 $a616.9 701 $aGiffin$b Robert B$01510132 701 $aRobinson$b Sally$0620917 712 02$aInstitute of Medicine (U.S.).$bForum on Drug Discovery, Development, and Translation. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910781187903321 996 $aAddressing the threat of drug-resistant tuberculosis$93742454 997 $aUNINA